XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Adjustment
Retained Earnings
Accumulated Other Comprehensive Loss
Adjustment
Total
Balance at Mar. 31, 2022 $ 221 $ 62,048   $ 104,931 $ (9,951)   $ 157,249
Balance (in shares) at Mar. 31, 2022 22,127,396            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       15,086     15,086
Cash dividends on common stock       (3,900)     (3,900)
Exercise of stock options   4         $ 4
Exercise of stock options (in shares) 1,511           1,511
Stock repurchased $ (7) (4,858)         $ (4,865)
Stock repurchased (in shares) (701,291)            
Restricted stock grants and forfeited, net (in shares) 68,719            
Stock-based compensation, net   292         292
Purchase of subsidiary shares from noncontrolling interest   (234)         (234)
Other comprehensive income (loss), net         (11,607)   (11,607)
Balance at Dec. 31, 2022 $ 214 57,252   116,117 (21,558)   152,025
Balance (in shares) at Dec. 31, 2022 21,496,335            
Balance at Sep. 30, 2022 $ 214 57,233   112,167 (22,452)   147,162
Balance (in shares) at Sep. 30, 2022 21,507,132            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       5,240     5,240
Cash dividends on common stock       (1,290)     (1,290)
Stock repurchased   (81)         (81)
Stock repurchased (in shares) (10,797)            
Stock-based compensation, net   100         100
Other comprehensive income (loss), net         894   894
Balance at Dec. 31, 2022 $ 214 57,252   116,117 (21,558)   152,025
Balance (in shares) at Dec. 31, 2022 21,496,335            
Balance at Mar. 31, 2023 $ 212 55,511 $ (53) 117,826 (18,310) $ (53) 155,239
Balance (in shares) at Mar. 31, 2023 21,221,960            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       6,767     6,767
Cash dividends on common stock       (3,806)     (3,806)
Exercise of stock options   36         $ 36
Exercise of stock options (in shares) 12,799           12,799
Stock repurchased $ (1) (576)         $ (577)
Stock repurchased (in shares) (109,162)            
Restricted stock grants and forfeited, net (in shares) (14,554)            
Stock-based compensation, net   11         11
Other comprehensive income (loss), net         855   855
Balance at Dec. 31, 2023 $ 211 54,982   120,734 (17,455)   158,472
Balance (in shares) at Dec. 31, 2023 21,111,043            
Balance at Sep. 30, 2023 $ 211 54,963   120,556 (23,691)   152,039
Balance (in shares) at Sep. 30, 2023 21,125,889            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       1,452     1,452
Cash dividends on common stock       (1,274)     (1,274)
Restricted stock grants and forfeited, net (in shares) (14,846)            
Stock-based compensation, net   19         19
Other comprehensive income (loss), net         6,236   6,236
Balance at Dec. 31, 2023 $ 211 $ 54,982   $ 120,734 $ (17,455)   $ 158,472
Balance (in shares) at Dec. 31, 2023 21,111,043